Antibiotic crisis: five minutes to midnight
In this issue:
- Antibiotic crisis: five minutes to midnight
- Digital Health: A bright future
- Bioeconomy: Industry rediscovers wood
- Interview with Mark Fahy, about why we’re seeing IPOs again
- Cancer: Oncologists evaluate clinical benefits in novel therapies
- CROs & CMOs: Generalists and specialists in the growing outsourcing market
- News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association